Related Experiment Video
Updated: Mar 31, 2026

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
[Latest advances in acute pancreatitis]
1Unidad de Patología Pancreática, Servicio de Aparato Digestivo, Hospital General Universitario de Alicante, Alicante, España; Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO), Alicante, España.
This review highlights key findings in acute pancreatitis management. Arterial pseudoaneurysms are rare, while cirrhosis increases mortality risk, and unsaturated fats may worsen severity.
Area of Science:
- Gastroenterology
- Hepatology
- Endocrinology
Background:
- Acute pancreatitis presents diverse clinical challenges.
- Understanding complications and risk factors is crucial for patient outcomes.
- Recent advancements offer new insights into management strategies.
Purpose of the Study:
- To summarize significant presentations on acute pancreatitis from Digestive Disease Week 2015.
- To highlight novel findings regarding complications, risk factors, and treatment modalities.
- To provide an overview of current research trends in acute pancreatitis.
Main Methods:
- Review of selected presentations from Digestive Disease Week 2015.
- Analysis of data on complications such as arterial pseudoaneurysm.
- Evaluation of the impact of comorbidities like diabetes mellitus and cirrhosis.
- Assessment of the role of imaging (PET-CT) and therapeutic interventions.
Main Results:
- Arterial pseudoaneurysm is a rare complication (0.7% incidence).
- Cirrhosis significantly increases mortality risk, unlike diabetes mellitus.
- Unsaturated fat intake may exacerbate pancreatitis severity.
- PET-CT shows potential for detecting infected collections.
- Peripancreatic fat necrosis is associated with a better prognosis than pancreatic necrosis.
- Percutaneous drainage can obviate surgery in 20% of severe cases.
- Low molecular-weight heparin may improve outcomes in moderate to severe pancreatitis.
- Simvastatin shows promise for preventing recurrent acute pancreatitis episodes.
- Nasogastric tube nutrition offers no advantage over oral nutrition.
Conclusions:
- Management of acute pancreatitis requires consideration of specific complications and comorbidities.
- Emerging tools and therapies, including heparin and simvastatin, warrant further investigation.
- Optimizing nutritional support and interventional strategies can improve patient care.
More Related Videos
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

